(Q48194189)

9 February 2018

http://europepmc.org/abstract/MED/28470777

title

CD38-negative relapse in multiple myeloma after daratumumab-based chemotherapy (English)

1 reference

9 February 2018

http://europepmc.org/abstract/MED/28470777

author

Jiri Minarik

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28470777%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Martin Novak

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28470777%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Patrik Flodr

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28470777%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Jana Balcarkova

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28470777%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Miroslava Mlynarcikova

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28470777%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Petra Krhovska

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28470777%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Tomas Pika

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28470777%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Zuzana Pikalova

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28470777%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Jaroslav Bacovsky

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28470777%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Vlastimil Scudla

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28470777%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

publication date

4 May 2017

1 reference

9 February 2018

http://europepmc.org/abstract/MED/28470777

published in

European Journal of Haematology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28470777%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28470777%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28470777%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

186-189

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28470777%20AND%20SRC:MED&resulttype=core&format=json

Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management

9 June 2020

cites work

1 reference

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

21 January 2018

1 reference

Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders

21 January 2018

1 reference

Immunophenotyping in multiple myeloma and related plasma cell disorders

21 January 2018

1 reference

New criteria for response assessment: role of minimal residual disease in multiple myeloma

21 January 2018

1 reference

Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.

21 January 2018

1 reference

Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma

21 January 2018

1 reference

Clonal competition with alternating dominance in multiple myeloma.

21 January 2018

1 reference

Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumab.

21 January 2018

1 reference

Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial

21 January 2018

1 reference

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma

21 January 2018

1 reference

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma

21 January 2018

1 reference

Transient down-modulation of CD20 by rituximab in patients with chronic lymphocytic leukemia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/EJH.12902

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28470777%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference